This year, the Scientific Research Committee (CWO) was launched. The CWO assesses all requests to start or participate in scientific studies.
Employees of Star-shl can initiate scientific research. They can also participate in scientific research conducted by others, for example by making knowledge, manpower and data available from Star-shl. After a general screening for suitability (content, basic information, elaboration) by one of the committee members, the applications are systematically evaluated on various criteria, including relevance to our customers, connection to the strategic themes, innovative value and feasibility. The CWO then advises the Board of Directors on the decision to be taken.
In 2020, the following studies were assessed and fed back to the applicant(s):
Applicants: LUMC and Breathomix
Agreement for study participation. The study has now also been successfully completed.
Applicant: UMCU
The study was provisionally approved just before the official start of CWO, but Star-shl’s participation was postponed due to interference with EVA 2.
Applicant: Erasmus MC
Agreement for study participation; study ongoing.
Applicant: Erasmus MC
Agreement for study participation; study ongoing.
Applicant: Erasmus MC
Agreement for study participation; study not yet started.
The CWO consists of Marieke Kruip (MD PhD, internist haematologist, medical director of the anticoagulation clinic), Khoa Thai (MD PhD, physician microbiologist), Rogier Hopstaken (MD PhD, general practitioner, innovation specialist), Zeeger Beukenhorst (LLM, lawyer) and Arnoud Frericks (MSc, secretary). Please direct new questions and requests to A.frericks@star-shl.nl